Hubei Engineering Center of Natural Polymers-based Medical Materials, College of Chemistry & Molecular Sciences, Wuhan University, Wuhan, 430072, China.
Department of Biological Repositories, Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Small. 2022 Mar;18(12):e2104885. doi: 10.1002/smll.202104885. Epub 2022 Feb 7.
Microbial infections and microbial resistance lead to a high demand for new antimicrobial agents. Quaternized polysaccharides are cationic antimicrobial candidates; however, the limitation of homogeneous synthesis solvents that affect the molecular structure and biological activities, as well as their drug resistance remains unclear. Therefore, the authors homogeneously synthesize a series of quaternized chitin (QC) and quaternized chitosan (QCS) derivatives via a green and effective KOH/urea system and investigate their structure-activity relationship and biological activity in vivo and in vitro. Their study reveals that a proper match of degree of quaternization (DQ) and degree of deacetylation (DD') of QC or QCS is key to balance antimicrobial property and cytotoxicity. They identify QCS-2 as the optimized antimicrobial agent with a DQ of 0.46 and DD' of 82%, which exhibits effective broad-spectrum antimicrobial properties, good hemocompatibility, excellent cytocompatibility, and effective inhibition of bacterial biofilm formation and eradication of mature bacterial biofilms. Moreover, QCS-2 exhibits a low propensity for development of drug resistance and significant anti-infective effects on MRSA in vivo comparable to that of vancomycin, avoiding excessive inflammation and promoting the formation of new blood vessels, hair follicles, and collagen deposition to thus expedite wound healing.
微生物感染和微生物耐药性导致对新型抗菌剂的高需求。季铵化多糖是阳离子型抗菌候选物;然而,影响分子结构和生物活性的均相合成溶剂的局限性以及它们的耐药性尚不清楚。因此,作者通过绿色有效的 KOH/尿素体系均匀合成了一系列季铵化壳聚糖(QC)和季铵化壳聚糖(QCS)衍生物,并研究了它们的结构-活性关系以及体内和体外的生物活性。他们的研究表明,QC 或 QCS 的季铵化程度(DQ)和脱乙酰化程度(DD')的适当匹配是平衡抗菌性能和细胞毒性的关键。他们确定 QCS-2 是优化的抗菌剂,DQ 为 0.46,DD'为 82%,具有有效的广谱抗菌性能、良好的血液相容性、优异的细胞相容性、有效抑制细菌生物膜形成和消除成熟细菌生物膜的作用。此外,QCS-2 表现出发展耐药性的倾向较低,对体内 MRSA 的抗感染效果与万古霉素相当,避免了过度炎症,并促进了新血管、毛囊和胶原蛋白的形成,从而加速了伤口愈合。